Interview: International Trachoma Initiative and Pfizer On Par To Eliminate and Eradicate Trachoma-caused Blindness
Thanks to advances in science and technology, the world is now on the cusp of eliminating several debilitating diseases that affect the world’s most disadvantaged populations. Many experts who have dedicated their careers to ending trachoma recently attended an international summit in Geneva (April 19-22, 2017) to discuss the progress to date. There a total of 10 neglected tropical diseases (NTDs) of the 18 identified by the World Health Organization being targeted by these international organizations and partnerships.
Trachoma is a leading infectious cause of blindness currently threatening about 185 million people ...
Source: Medgadget - May 2, 2017 Category: Medical Equipment Authors: Alice Ferng Tags: Exclusive Public Health Source Type: blogs
Interview: International Trachoma Initiative and Pfizer On Par To Eliminate and Eradicate Trachoma-caused Blindness
Thanks to advances in science and technology, the world is now on the cusp of eliminating several debilitating diseases that affect the world’s most disadvantaged populations. Many experts who have dedicated their careers to ending trachoma recently attended an international summit in Geneva (April 19-22, 2017) to discuss the progress to date. There a total of 10 neglected tropical diseases (NTDs) of the 18 identified by the World Health Organization being targeted by these international organizations and partnerships.
Trachoma is a leading infectious cause of blindness currently threatening about 185 million people ...
Source: Medgadget - May 2, 2017 Category: Medical Equipment Authors: Alice Ferng Tags: Exclusive Public Health Source Type: blogs
Interview: International Trachoma Initiative and Pfizer On Par To Eliminate Trachoma-caused Blindness
Thanks to advances in science and technology, the world is now on the cusp of eliminating several debilitating diseases that affect the world’s most disadvantaged populations. Many experts who have dedicated their careers to ending trachoma recently attended an international summit in Geneva (April 19-22, 2017) to discuss the progress to date. There a total of 10 neglected tropical diseases (NTDs) of the 18 identified by the World Health Organization being targeted by these international organizations and partnerships.
Trachoma is a leading infectious cause of blindness currently threatening about 185 million people ...
Source: Medgadget - May 2, 2017 Category: Medical Equipment Authors: Alice Ferng Tags: Exclusive Public Health Source Type: blogs
Lessons from the Reagan Tax Cuts
In acolumn in today ’s New York Times, Steven Rattner attacks Trump ’s tax plan for being unrealistic. SinceI also think the proposal isn ’t very plausible, I ’m not overly bothered by that message. However, Rattner tries to bolster his case by making very inaccurate and/or misleading claims about the Reagan tax cuts.Givenmy admiration for the Gipper, those assertions cry out for correction. Starting with his straw man claim that the tax cuts were supposed to pay for themselves.…four decades ago…the rollout of what proved to be among our country’s greatest economic follies — the alchemistic belief that hug...
Source: Cato-at-liberty - May 1, 2017 Category: American Health Authors: Daniel J. Mitchell Source Type: blogs
Making Life More Fulfilling for Older Adults with Low Vision
Many people would consider losing their sight one of the worst potential losses that they could encounter. While most of us will not suffer from complete blindness, millions currently suffer from some form of visual impairment, with numbers growing rapidly as we age. According to the National Eye Institute (NEI), older adults represent the majority of the visually impaired population, with visual impairment included among the 10 most prevalent causes of disability in the U.S.
Read full article on Agingcare about making life easier for those with low vision:
Support a caregiver or jump star...
Source: Minding Our Elders - April 22, 2017 Category: Geriatrics Authors: Carol Bradley Bursack Source Type: blogs
Value Frameworks For Rare Diseases: Should They Be Different?
The US health care system is increasingly focusing on value as a basis for reimbursement of pharmacotherapies and devices, and as a result the use of “value frameworks” for measuring and comparing treatment value has grown in recent years. However, the therapies assessed by most frameworks frequently apply to modest-to-large disease populations, rather than the smaller populations affected by rare diseases, where the factors driving value may differ.
Rare diseases are different from diseases affecting larger populations in several fundamental ways. In the United States, a rare disease is defined as one that affects few...
Source: Health Affairs Blog - April 12, 2017 Category: Health Management Authors: Anupam Jena and Darius Lakdawalla Tags: Costs and Spending Drugs and Medical Innovation Quality Orphan Drug Act Precision Medicine rare disease treatment treatment value value frameworks Source Type: blogs
Ageism In Healthcare And The Danger Of Senior Profiling
We’ve all heard the saying, “age is just a number.” Nowhere is that more important than in the hospital setting. Over the years I’ve become more and more aware of ageism in healthcare – a bias against full treatment options for older patients. Assumptions about lower capabilities, cognitive status and sedentary lifestyle are all too common. There is a kind of “senior profiling” that occurs among hospital staff, and this regularly leads to inappropriate medical care.
Take for example, the elderly woman who was leading an active life in retirement. She was the chairman of the boar...
Source: Better Health - March 27, 2017 Category: American Health Authors: Dr. Val Jones Tags: Health Policy True Stories Ageism Bias healthcare Medicine Rehabilitation Senior Profiling Seniors Source Type: blogs
Fight Aging! Newsletter, March 27th 2017
In conclusion, DNAm of multiple disease-related genes are strongly linked to mortality outcomes.
The recently established epigenetic clock (DNAm age) has received growing attention as an increasing number of studies have uncovered it to be a proxy of biological ageing and thus potentially providing a measure for assessing health and mortality. Intriguingly, we targeted mortality-related DNAm changes and did not find any overlap with previously established CpGs that are used to determine the DNAm age. Our findings are in line with evidence, suggesting that DNAm involved in ageing or health-related outcomes are mostly...
Source: Fight Aging! - March 26, 2017 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
My Incredible Results From The Whole30
I have long believed that self development isn’t just about changing the way we think.
Yes, that’s crucially important because if we think the same way, then for the most part nothing changes other than through blind luck.
It’s why I talk to clients about meditation and ask them about exercise and diet/nutrition.
Not that I would offer advice on the latter two subjects other than very, very generally, such as, ‘maybe it’s better to work out sometimes and not eat crap all the time?’
Sometime around 2008 I started getting interested in the Primal Solution and Paleo lifestyle.
In the subsequent time so muc...
Source: A Daring Adventure - March 24, 2017 Category: Psychiatry & Psychology Authors: Tim Brownson Tags: Other Business Source Type: blogs
Digging in to the Mechanisms of A2E in Macular Degeneration
An accumulation of the metabolic waste compound A2E in the retina is associated with the progression of degenerative blindness via conditions such as macular degeneration, and there is strong indirect evidence for it to be a cause of the condition. This is one of numerous forms of waste that accumulate to form lipofuscin deposits inside and outside cells in the retina, but most likely the most important form. The easiest way to prove that causation beyond doubt, and hopefully also develop therapies that actually reverse retinal damage, is to selectively break down and remove A2E. An effort based on drug candidates develope...
Source: Fight Aging! - March 21, 2017 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
An Interview with Kelsey Moody of Ichor Therapeutics
The Life Extension Advocacy Foundation here interviews Kelsey Moody of Ichor Therapeutics, a company working on clinical translation of the SENS rejuvenation research approach to clearing one of the forms of persistent metabolic waste that causes aging and age-related disease. In this case, it is a type of waste product that is generated in the energetic cells of the retina; as it accumulates, it leads to macular degeneration and progressive blindness:
New medical technologies need bold researchers to make the leap from the laboratory table to hospitals and clinics where they can improve or even save lives. Kelsey...
Source: Fight Aging! - March 15, 2017 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
An Update on the Use of Gene Therapies to Convert Retinal Cells
A few years back, researchers reported on a novel approach to treating the degenerative blindness of retinitis pigmentosa, an inherited condition in which the rod photoreceptor cells responsible for low-light and peripheral vision become progressively more dysfunctional, eventually leading to the death of other retinal cells. The researchers found that tinkering with levels of Nrl in retinal tissues can make rod cells transform into something more like the cone cells responsible for color vision. In normal development of retinal photoreceptor cells, those with a lot of Nrl become rods, while those with less become cones, b...
Source: Fight Aging! - March 15, 2017 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs
Artificial Retina Made of Organic Photovoltaic Material Lets Blind Rats See
A team of Italian researchers has developed an artificial retina that, in essence, functions like a self-powering solar panel. The fully organic retinal prosthesis was implanted into the eyes of rats with retinitis pigmentosa, which allowed them to see for months after surgery.
Artificial retinal implant inside eye of “Royal College of Surgeons” breed of rat. Image courtesy of Fabio Benfenati
The implant consists of an organic semiconductor, a photovoltaic which turns light into current, and a conductive polymer to interface with the back of the eye, both placed on top of a substrate of silk. The silk helps the...
Source: Medgadget - March 14, 2017 Category: Medical Equipment Authors: Editors Tags: Ophthalmology Source Type: blogs
